See Zekeridou and Lennon (doi: 10.1093/aww213 ) for a scientific commentary on this
article . Anti- N -methyl-D-aspartate receptor (NMDAR) encephalitis is a recently discovered …

The emergence of SARS-CoV-2 led to pandemic spread of coronavirus disease 2019 (COVID-19),
manifesting with respiratory symptoms and multi-organ dysfunction. Detailed …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Beta variant of concern (VOC)
resists neutralization by major classes of antibodies from COVID-19 patients and …

Seizures are a prominent feature in N-Methyl-D-Aspartate receptor antibody (NMDAR
antibody) encephalitis, a distinct neuro-immunological disorder in which specific human …

Neurological symptoms are seen in patients with COVID-19 and can persist or re-emerge
after clearance of SARS-CoV-2. Recent findings suggest that antibodies to SARS-CoV-2 can …

Neutralizing antibodies (nAbs) elicited against the receptor binding site (RBS) of the spike
protein of wild-type severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are …

Background COVID-19 intensive care patients can present with neurological syndromes,
usually in the absence of SARS-CoV-2 in cerebrospinal fluid (CSF). The recent finding of some …

Autoantibodies targeting neuronal membrane proteins can cause encephalitis, seizures, and
severe behavioral abnormalities. While antibodies for several neuronal targets have been …

For coronavirus disease 2019 (COVID-19), effective and well-understood treatment options
are still scarce. Since vaccine efficacy is challenged by novel variants, short-lasting immunity…

Objective Leucine‐rich glioma‐inactivated 1 (LGI1) encephalitis is the second most common
antibody‐mediated encephalopathy, but insight into the intrathecal B‐cell autoimmune …